Gonococcal antimicrobial susceptibility surveillance in Europe 2009
Since 2009, the European Centre for Disease Prevention and Control has coordinated the enhanced surveillance of sexually transmitted infections in Europe.
Second external quality assurance scheme for Salmonella typing
Thirty-five laboratories of the Food- and Waterborne Diseases and Zoonoses Network (FWD-Net), among them 28 from EU/EEA countries, participated in the second international external quality assurance (EQA) scheme for the typing of Salmonella.
External quality assurance scheme for diphtheria diagnostics 2010
This report presents the results of the 2010 EQA exercise that assessed the capabilities of diagnosing diphtheria in 28 reference laboratories across Europe. Participating centres were asked to complete a questionnaire and identify six simulated throat specimens.
Antimicrobial resistance surveillance in Europe 2010
This report presents antimicrobial resistance data reported to EARS-Net by 28 countries for 2010 with trend analyses for the period 2007-2010. This edition also includes a focus chapter on carbapenem-resistant K. pneumoniae and P. aeruginosa.
Third external quality assurance scheme for Salmonella typing
The third external quality assurance scheme for Salmonella typing, launched in November 2010, assessed whether typing of Salmonella strains by different laboratories within and outside the European Union was carried out uniformly and whether comparable results could be obtained.
External quality assurance scheme for typing of verocytotoxin-producing E. coli (VTEC)
This report presents the results of the second round of the external quality assurance scheme for typing of verocytotoxin-producing Escherichia coli.
CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.